Novo Nordisk (NVO.N) said the world’s first and currently only approved weekly basal insulin/GLP‑1 receptor agonist, icodec/semaglutide injection, has launched in China. The product is approved for adults with type 2 diabetes whose blood glucose remains uncontrolled on basal insulin or a GLP‑1 RA, to be used with oral glucose‑lowering drugs alongside diet and exercise.

Russia presidential aide USHAKOV said Putin and US President Trump held a 55-minute phone call covering bilateral ties and international issues including Iran and the Ukraine crisis. Trump told Putin a US-Iran agreement is near completion after complex talks mediated by Pakistan and Qatar and could be announced the same day. USHAKOV said a US special envoy and Trump’s son‑in‑law Jared Kushner will visit Moscow soon.

JP Morgan Asset Management's EMEA chief market strategist Karen Ward said a sharp fall in oil could power equities by reigniting the rotation halted by the Iran conflict. As a U.S.-Iran agreement takes shape, she said oil could fall to $70/bbl in the coming weeks. Supply upside may come not only from Iran but from weakening OPEC cohesion and Gulf producers monetizing reserves, creating a material tailwind for stocks and potentially prompting central banks to cut rates. Ward added the sector- and regional-rotation seen last year was interrupted on Feb. 27 but is now re-emerging as the shock fades.